Challenges in diagnosing and managing adult patients with urea cycle disorders
Corresponding Author
Karolina M. Stepien
Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford, UK
Correspondence
Karolina M. Stepien, Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK.
Email: [email protected]
Search for more papers by this authorTarekegn Geberhiwot
Centre for Endocrinology, Diabetes and Metabolism, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Search for more papers by this authorChristian J. Hendriksz
Department of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa
Search for more papers by this authorEileen P. Treacy
National Centre for Inherited Metabolic Diseases, The Mater Misericordiae University Hospital, Dublin, Ireland
Department of Paediatrics, Trinity College, Dublin, Ireland
Search for more papers by this authorCorresponding Author
Karolina M. Stepien
Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford, UK
Correspondence
Karolina M. Stepien, Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK.
Email: [email protected]
Search for more papers by this authorTarekegn Geberhiwot
Centre for Endocrinology, Diabetes and Metabolism, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Search for more papers by this authorChristian J. Hendriksz
Department of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa
Search for more papers by this authorEileen P. Treacy
National Centre for Inherited Metabolic Diseases, The Mater Misericordiae University Hospital, Dublin, Ireland
Department of Paediatrics, Trinity College, Dublin, Ireland
Search for more papers by this authorAbstract
Urea cycle disorders (UCD) are a group of rare inherited metabolic conditions of amino acid catabolism caused by an enzyme deficiency within the hepatic ammonia detoxification pathway. The presentation of these disorders ranges from life-threatening intoxication in the neonate to asymptomatic status in adults. Late-onset UCDs can present for the first time in adulthood and may mimic other causes of acute confusion or psychiatric diseases, and are often associated with neurological symptoms. Late-onset UCDs may become apparent during periods of metabolic stress such as rapid weight loss, gastric bypass surgery, chronic starvation or the postpartum period. Early diagnosis is critical for effective treatment and to prevent long-term complications of hyperammonemia. The challenges of management of adults include for example: (a) poor compliance to dietary and medical treatment which can result in recurrent hospital admissions; (b) severe neurological dysfunction; (c) the management of pregnancy and the postpartum period; and (d) access to multidisciplinary care peri-operatively. In this review, we highlight a number of challenges in the diagnosis and management of adult patient with late-onset UCDs and suggest a systematic management approach.
CONFLICT OF INTEREST
Authors have no conflict of interest for this article.
REFERENCES
- 1Batshaw ML, Tuchman M, Summar M, Seminara J, Members of the Urea Cycle Disorders Consortium. A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014; 113(1-2): 127-130.
- 2Cavicchi C, Donati M, Parini R, et al. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-clues for early diagnosis and timely treatment. Orphanet J Rare Dis. 2014; 9: 105.
- 3Rohininath T, Costello DJ, Lynch T, Monavari A, Tuchman M, Treacy EP. Fatal presentation of ornithine transcarbamylase deficiency in a 62-year-old man and family studies. J Inherit Metab Dis. 2004; 27: 285-288.
- 4Saudubray JM, Mochel F. The phenotype of adult versus pediatric patients with inborn errors of metabolism. J Inherit Metab Dis (ahead of print. 2018; 41: 753-756. https://doi.org/10.1007/s10545-018-0209-9.
- 5Summar ML, Dobbelaere D, Brusilow S, Lee B. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr. 2008; 97: 1420-1425.
- 6Caldovic L, Morizono H, Panglao MG, et al. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum Genet. 2005; 25: 293-298.
- 7Ficicioglu C, Mandell R, Shih VE. Argininosuccinate lyase deficiency longterm outcome of 13 patients detected by newborn screening. Mol Genet Metab. 2009; 98: 273-277.
- 8Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG. Mild citrullinaemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinaemia type 1). Mol Genet Metab. 2003; 80: 302-306.
- 9Kurokawa K, Yorifuji T, Kawai M, et al. Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency. J Hum Genet. 2007; 52: 349-354.
- 10Enns GM. Neurologic damage and neurocognitive dysfunction in urea cycle disorder. Semin Pediatr Neurol. 2008; 15: 132-139.
- 11McCullough BA, Yudkoff M, Batshaw ML, Wilson JM, Raper SE, Tuchman M. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet. 2000; 93(4): 313-319.
10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 12Plochl W, Plochl E, Pokorny H, et al. Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency. Transpl Int. 2001; 14: 196-201.
- 13Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med. 2007; 356: 2282-2292.
- 14Summar ML, Barr F, Dawling S, et al. Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin. 2005; 21: S1-S8.
- 15 AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V., AWMF) online. Revision UCD Guideline (2018). https://www.awmf.org/uploads/tx_szleitlinien/027-006l_S3_Diagnostik-Therapie-Harnstoffzyklusstoerungen_2018-06.pdf. Date January 1, 2019.
- 16Alameri M, Shakra M, Alsaadi T. Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report. Austin J Clin Neurol. 2015; 2(8): 1-3.
- 17Bigot A, Brunault P, Lavigne C, et al. Psychiatric adult-onset of urea cycle disorders: a case-series. Mol Genet Metab Rep. 2017; 12: 103-109.
- 18Häberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012; 7: 32.
- 19Sloas HA 3rd, Ence TC, Mendez DR, Cruz AT. At the intersection of toxicology, psychiatry and genetics: a diagnosis of ornithine transcarbamylase deficiency. Am J Emerg Med. 2013; 31: 1420e5-1420e6.
- 20Ben-Ari Z, Dalal A, Morry A, et al. Adult onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins diet. J Hepatol. 2010; 52: 292-295.
- 21Daijo K, Kawaoka T, Nakahara T, et al. Late-onset ornithine transcabamylase deficiency associated with hyperammonaemia. Clin J Gastroenterol. 2017; 10(4): 383-387.
- 22Lee CH, Ellaway C, Shun A, et al. Split-graft liver transplantation from an adult donor with an unrecognized UCD to a pediatric and adult recipient. Pediatr Transplant. 2017; 22: e13073.
- 23Ramanathan M, Uppalapu S, Patel NM. Hiding in plain sight: a case of ornithine transcarbamylase deficiency unmasked post-liver transplantation. Am J Transplant. 2017; 17: 1405-1408.
- 24Weiss N, Mochel F, Rudler M, et al. Peak hyperammonaemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum. J Hepatol. 2018; 68: 185-192.
- 25Wells DL, Thomas JB, Sacks GS, Zouhary LA. Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition. Nutrition. 2014; 30: 943-947.
- 26Häberle J, Vilaseca MA, Meli C, et al. First manifestation of citrullinaemia type I as differential diagnosis to postpartum psychosis in the puerperal period. Eur J Obstet Gynecol Reprod Biol. 2010; 149: 228-229.
- 27Reid L, Perreault E, Lafrance G, Clarke JT. Experience with the treatment of argininosuccinic aciduria during pregnancy. J Inherit Metab Dis. 2009; 32(Suppl 1): S191-S195.
- 28Salek J, Byrne J, Box T, Longo N, Sussman N. Recurrent liver failure in a 25-year-old female. Liver Transpl. 2010; 16(9): 1049-1053.
- 29Van de Logt AE, Kluijtmans LAJ, Huiden MACDG, Hanssen MCH. Hyperammonaemia due to adult-onset N-acetylglutamate synthase deficiency. JIMD Rep. 2017; 31: 95-99.
- 30Bonnot O, Herrera PM, Tordjman S, Walterfang M. Secondary psychosis induced by metabolic disorders. Front Neurosci. 2015; 9: 177.
- 31Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014; 13: 27.
- 32Walterfang M, Bonnot O, Mocellin R, Velakoulis D. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis. 2013; 36: 687-702.
- 33Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007; 30: 631-641.
- 34Yamamoto N, Tsutsui K, Yamamoto M, Arakaki H, Kurumaji A, Nishikawa T. Sliding doors (but not with beans or tofu). Lancet. 2008; 372: 1782.
- 35Gropman AL, Batshaw ML. Cognitive outcome in urea cycle disorders. Mol Genet Metab. 2004; 81(Suppl 1): S58-S62.
- 36Limketkai BN, Zucker SD. Hyperammonaemic encephalopathy caused by carnitine deficiency. J Gen Intern Med. 2007; 23: 210-213.
- 37Sakusic A, Sabov M, McCambridge AJ. Features of adult hyperammonaemia not due to liver failure in the ICU. Crit Care Med. 2018; 46(9): e897-e903.
- 38Gropman AL, Summar M, Leonard JV. Neurological implications of urea cycle disorders. J Inherit Metab Dis. 2007; 30: 865-879.
- 39Grünewald S, Fairbanks L, Genet S, et al. How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency? J Inherit Metab Dis. 2004; 27: 179-186.
- 40Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat. 2006; 27(7): 626-632.
- 41Gropman A. Brain imaging in urea cycle disorders. Mol Genet Metab. 2010; 100(Suppl 1): S20-S30.
- 42Gropman AL, Gertz B, Shattuck K, et al. Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency. Am J Neuroradiol. 2010; 31: 1719-1723.
- 43Gropman AL, Prust M, Breeden A, Fricke S, VanMeter J. Urea cycle defects and hyperammonemia: effects on functional imaging. Metab Brain Dis. 2013; 28: 269-275.
- 44Gropman AL, Seltzer RR, Yudkoff M, et al. 1H MRS allows brain phenotype differentiation in sister with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations. Mol Genet Metab. 2008; 94: 52-60.
- 45Scaglia F, Carter S, O'Brien WE, Lee B. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol Genet Metab. 2004; 81(Suppl 1): S79-S85.
- 46Bates TR, Lewis BD, Burnett JR, et al. Late-onset carbamoyl phosphate synthetase 1 deficiency in an adult cured by liver transplantation. Liver Transpl. 2011; 17: 1481-1484.
- 47Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. Ornithine transcarbamylase deficiency. In: RA Paragon, MP Adam, HH Ardinger, et al., eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 2013: 1993-2015.
- 48Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. J Inherit Metab Dis. 2005; 28: 407-414.
- 49Mahmood T, Nugent K. Nonhepatic hyperammonaemic encephalopathy due to undiagnosed urea cycle disorder. Proc (Bayl Univ Med Cent). 2015; 28(3): 375-377.
- 50Waisbren S, Gropman A, Members of the UCDCM, Batshaw ML. Improving long term outcomes in urea cycle disorders—report from the urea cycle disorders consortium. J Inherit Metab Dis. 2016; 39(4): 573-584.
- 51Häberle J, Koch HG. Genetic approach to prenatal diagnosis in urea cycle defects. Prenat Diagn. 2004; 24: 378-383.
- 52Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KL, Batshaw ML. Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res. 2009; 66: 96-101.
- 53Rüegger CM, Lindner M, Ballhausen D, et al. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis. 2014; 37: 21-30.
- 54Feillet F, MacDonald A, Hartung Perron D, Burton B. Outcomes beyond phenylalanine: an international perspective. Mol Genet Metab. 2010; 99(Suppl 1): S79-S85.
- 55Sinclair M, Ket S, Testro A, Gow PJ, Angus PW. Acute hepatic decompensation precipitated by pregnancy-related catabolic stress: a rare mimic of acute liver failure. Obstet Gynecol. 2014; 123(2 Pt 2 Suppl 2): 480-483.
- 56Laemmle A, Gallagher RC, Keogh A, et al. Frequency and pathophysiology of acute liver failure in ornithine Transcarbamylase deficiency (OTCD). PLoS One. 2016; 11(4): e0153358.
- 57London V, Grube S, Sherer DM, Abulafia O. Hyperemesis gravidarum: a review of recent literature. Pharmacology. 2017; 100(3–4): 161-171.
- 58Bailly P, Noury JB, Timsit S, Ben SD. Teaching NeuroImages: ornithine transcarbamylase deficiency revealed by a coma in a pregnant woman. Neurology. 2015; 85(20): e146-e147.
- 59Crosbie DC, Sugumar H, Simpson MA, Walker SP, Dewey HM, Reade MC. Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma. Crit Care Resusc. 2009; 11(3): 222-227.
- 60Eather G, Coman D, Lander C, McGill J. Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-yearold. J Clin Neurosci. 2006; 13(6): 702-706.
- 61Frassier T, Guffon N, Acquaviva C, D'Amato T, Durand DV, Domenech P. Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry. 2011; 168: 576-580.
- 62Brusilow SW, Horwich AL. Urea cycle enzymes. In: CR Scriver, D Beaudet, D Valle, WS Sly, eds. The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001: 1909-1961.
- 63Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr. 2001; 138: S46-S54.
- 64Leonard JV, Ward Platt MP, Morris AA. Hypothesis: proposals for the management of a neonate at risk of hyperammonaemia due to a urea cycle disorder. Eur J Pediatr. 2008; 167: 305-309.
- 65Meyburg J, Hoffman GF. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab. 2010; 100(Suppl 1): S77-S83.
- 66Chadefaux-Vekemans B, Rabier D, Chabli A, et al. Improving the prenatal diagnosis of citrullinemia using citrulline/ornithine+arginine ratio in amniotic fluid. Prenat Diagn. 2002; 22: 456-458.
- 67Mokhtarani M, Diaz GA, Rhead W, et al. Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PA to PAGN ratio. Mol Genet Metab. 2013; 110(4): 446-453.
- 68Häberle J, McCandless SE. Orphan drugs in development for urea cycle disorders: current perspectives. Orphan Drugs: Res Rev. 2014; 4: 63-70.
- 69Viecelli HM, Thöny B. Challenges of experimental gene therapy for urea cycle disorders. J Pediatr Biochem. 2014; 4: 65-73.
- 70Lee AL, Sinha S, Fitzpatrick E, Dhawan A. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med. 2018; 96: 469-481.
- 71Sokal EM. Treating inborn errors of liver metabolism with stem cells: current clinical development. J Inherit Metab Dis. 2014; 37(4): 535-539.